Diagnosis and Treatment of Cervical Lymphadenitis from a Standpoint of Infectious Disease Specialists

Joon Young Song; Hee Jin Cheong

doi:10.3947/ic.2008.40.2.76

Journal List > Infect Chemother > v.40(2) > 1075447

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Song and Cheong: Diagnosis and Treatment of Cervical Lymphadenitis from a Standpoint of Infectious Disease Specialists

Special Article

Infection and Chemotherapy

Infection and Chemotherapy 2008; 40(2): 76-82.

Published online: 20 April 2008

DOI: https://doi.org/10.3947/ic.2008.40.2.76

Diagnosis and Treatment of Cervical Lymphadenitis from a Standpoint of Infectious Disease Specialists

Joon Young Song, M.D., Hee Jin Cheong, M.D.

Division of Infectious Disease, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.

Correspondence: Hee Jin Cheong, M.D. Division of Infections Disease, Department of internal Medicine, Korea University College of Medicine, 37, Guro-gu, Seoul 152-703, Korea. Tel: 82-2-2626-3050, Fax: 82-2-837-1966, heejinmd@medimail.co.kr

Received 20 March 2007 Accepted 10 April 2008

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Cervical lymphadenitis is one of the common causes which make the patients visit the outpatient clinic. Extensive differential diagnoses are required to identify causative illness including viral or bacterial infection, Kikuchi's disease, tuberculosis, etc. In this review, several important key points are discussed with regards to clinical course, pathological diagnosis and treatment in patients with cervical lymphadenitis.

Keywords: Cervical lymphadenitis, Pathology, Treatment

Figures and Tables

Table 1

Cervical Lymphadenitis Requiring Biopsy

Table 2

Sensitivity and Specificity of FNA-based Diagnostic Methods for Tuberculous Lymphadenitis

FNA, fine needle aspiration; PCR, polymerase chain reaction; MIGIT, Mycobacteria growth indicator tube; LJ, Lowenstein-Jensen

^*In-house PCR vs. COBAS AMPLICOR MTB PCR

Table 3

Clinical and Radiological Comparison among Tuberculous Lymphadenitis, Histiocytic Necrotizing Lymphadenitis and Reactive Lymphadenitis

References

1. Kubota T. The evaluation of peripheral adenopathy. Primary Care. 1980. 7:461.

2. Habermann TM, Steensma DP. Lymphadenopathy. Mayo Clin Proc. 2000. 75:723.

3. Moore SW, Schneider JW, Schaaf HS. Diagnostic aspects of cervical lymphadenopathy in children in the developing world: a study of 1,877 surgical specimens. Pediatr Surg Int. 2003. 19:240–244.

4. Williamson HA Jr. Lymphadenopathy in a family practice: A descriptive study of 240 cases. J Fam Pract. 1985. 20:449.

5. Song JY, Cheong HJ, Kee SY, Lee J, Sohn JW, Kim MJ, Seo SI, Kim IS, Kim WJ. Disease spectrum of cervical lymphadenitis: analysis based on ultrasoundguided core-needle gun biopsy. J Infect. 2007. 55:310–316.

6. Ferrer R. Lymphadenopathy: Differential diagnosis and evaluation. Am Fam Physician. 1998. 58:1313.

7. Lee JY, Kang JS, Kim MK, Hwang TS, Kwak YG, Chae MB, Jang CS, Kim IK, Seo DB, Chung MH. The Prevalence of Bartonella henselae Infection in Korean Feral Cats. Korean J Infect Dis. 2001. 33:319–324.

8. Chung JY, Han TH, Kim BN, Yoo YS, Lim SJ. Detection of bartonella henselae DNA by polymerase chain reaction in a patient with cat scratch disease: A case report. J Korean Med Sci. 2005. 20:888–891.

9. Kim EK, Kwak JY, You JK, Park CS, Chung WY, Yang WI, Oh KK. Usefullness of ultrasound-guided core needle biopsy in the diagnosis of cervical lymphadenopathy. J Korean Soc Med Ultrasound. 2003. 22:233–238.

10. Cho DI. Tuberculous cervical lymphadenitis. Tuberc Respir Dis. 1997. 44:957–963.

11. Lai KK, Stottmeier KD, Sherman IH, McCabe WR. Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age. JAMA. 1984. 251:1286–1288.

12. Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis. 1995. 20:954–963.

13. Schaad UB, Votteler TP, McCracken GH Jr, Nelson JD. Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. J Pediatr. 1997. 95:356–360.

14. Ord RF, Matz GJ. Tuberculous cervical lymphadenitis. Arch Otolaryngol. 1974. 99:327–329.

15. Artenstein AW, Kim JH, Williams WJ, Chung RC. Isolated peripheral tuberculous lymphadenitis in adults: current clinical and diagnostic issues. Clin Infect Dis. 1995. 20:876–882.

16. Kidane D, Olobo JO, Habte A, Negesse Y, Aseffa A, Abate G, Yassin MA, Bereda K, Harboe M. Identification of the causative organism of tuberculous lymphadenitis in ethiopia by PCR. J Clin Microbiol. 2002. 40:4230–4234.

17. Baek CH, Kim SI, Ko YH, Chu KC. Polymerase chain reaction detection of Mycobacterium tuberculosis from fine-needle aspirate for the diagnosis of cervical tuberculous lymphadenitis. Laryngoscope. 2000. 110:30–34.

18. Kim SS, Chung SM, Kim JN, Lee MA, Ha EH. Application of PCR from the fine needle aspirates for the diagnosis of cervical tuberculous lymphadenitis. J Korean Med Sci. 1996. 11:127–132.

19. Rimek D, Tyagi S, Kappe R. Performance of an IS6110-based PCR assay and the COBAS AMPLICOR MTB PCR system for detection of Mycobacterium tuberculosis complex DNA in human lymph node samples. J Clin Microbiol. 2002. 40:3089–3092.

20. Yassin MA, Olobo JO, Kidane D, Negesse Y, Shimeles E, Tadesse A, Demissie A, Britton S, Harboe M, Aseffa A, Abate G. Diagnosis of tuberculous lymphadenitis in Butajira, rural Ethiopia. Scand J Infect Dis. 2003. 35:240–243.

21. Aljafari AS, Khalil EA, Elsiddig KE, El Hag IA, Ibrahim ME, Elsafi ME, Hussein AM, Elkhidir IM, Sulaiman GS, Elhassan AM. Diagnosis of tuberculous lymphadenitis by FNAC, microbiological methods and PCR: a comparative study. Cytopathology. 2004. 15:44–48.

22. Manitchotpisit B, Kunachak S, Kulapraditharom B, Sura T. Combined use of fine needle aspiration cytology and polymerase chain reaction in the diagnosis of cervical tuberculous lymphadenitis. J Med Assoc Thai. 1999. 82:363–368.

23. Memish ZA, Mah MW, Mahmood SA, Bannatyne RM, Khan MY. Clinico-diagnostic experience with tuberculous lymphadenitis in Saudi Arabia. Clin Microbiol Infect. 2000. 6:137–141.

24. Singh KK, Muralidhar M, Kumar A, Chattopadhyaya TK, Kapila K, Singh MK, Sharma SK, Jain NK, Tyagi JS. Comparison of in house polymerase chain reaction with conventional techniques for the detection of Mycobacterium tuberculosis DNA in granulomatous lymphadenopathy. J Clin Pathol. 2000. 53:355–361.

25. Kim JH. Bacille Calmette-Guerin (BCG) and tuberculin skin test. Infect and Chemother. 2004. 36:Suppl2. S117–S123.

26. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax. 2002. 57:804–809.

27. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA. 2005. 293:2756–2761.

28. Kim MJ. Diagnosis and Treatment of Extrapulmonary Tuberculosis. Infect and Chemother. 2004. 36:Suppl2. S124–S131.

29. Campbell IA, Dyson AJ. Lymph node tuberculosis: a comparison of treatments 18 months after completion of chemotherapy. Tubercle. 1979. 60:95–98.

30. British Thoracic Society Research Committee. Short course chemotherapy for tuberculosis of lymph nodes: a controlled trial. Br Med J. 1985. 290:1106–1108.

31. Jung DS, Kwon KT, Cheong HS, Rhee JY, Shin SY, Oh WS, Ko KS, Peck KR, Lee NY, Song JH. Clinical characteristics and predictive factors of paradoxical response with cervical lymph node tuberculosis in non-HIV-infected adult patients. Infect and Chemother. 2006. 38:Suppl2. S219.

32. Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, Lau SK, Yuen KY. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002. 21:803–809.

33. Bosch X, Guilabert A. Kikuchi-Fujimoto disease. Orphanet J Rare Dis. 2006. 1:18–20.

34. Kuo TT. Kikuchi's disease (histiocytic necrotizing lymphadenitis): a clinico-pathological study of 79 cases with an analysis of histologic subtypes, immunohistology and DNA ploidy. Am J Surg Pathol. 1995. 19:798–809.

35. Takano Y, Saegusa M, Okudaira M. Pathologic analyses of non-overt necrotizing type Kikuchi and Fujimoto's disease. Acta Pathol Jpn. 1993. 43:635–645.

36. Mohanty SK, Arora R, Saha M. Kikuchi-Fujimoto disease: an overview. J Dermatol. 2002. 29:10–14.

37. Yasukawa K, Matsumura T, Sato-Matsumura KC. Kikuchi's disease and the skin: case report and review of the literature. Br J Dermatol. 2001. 144:885–889.

38. Tong TR, Chan OW, Lee KC. Diagnosing Kikuchi disease on fine needle aspiration biopsy: a retrospective study of 44 cases diagnosed by cytology and 8 by histopathology. Acta Cytol. 2001. 45:953–957.

39. Choi JW, Lee JH, Chae YS, Kim I. The clinicopathologic analysis of Kikuchi's lymphadenitis. Korean J Pathol. 2004. 38:289–294.

TOOLS

Similar articles